Fibromyalgia Treatment Market Growth, Trends and Key Players (2024 – 2032)

The global fibromyalgia treatment market is projected to expand from USD 2.77 billion in 2023 to approximately USD 4.13 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2032.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5139 

Report Highlights:

• Ongoing development of new and innovative treatment options for fibromyalgia.
• Increasing demand for fibromyalgia treatments driving market growth.
• Medications held the largest market share at 68% in 2023.
• Retail pharmacies were the leading distributors, capturing 54% of the market share in 2023.
• North America was the largest market contributor, accounting for 40% of the global share in 2023.

Fibromyalgia affects around 4 million adults in the United States, roughly 2% of the adult population. While the exact cause remains unknown, effective treatment options are available. As the need for these treatments grows, researchers are exploring new approaches beyond traditional medications.

Fibromyalgia is characterized by widespread muscle pain, fatigue, difficulty concentrating, and other emotional and physical symptoms. Although people with fibromyalgia experience pain in muscles and soft tissues, there is no visible inflammation in these areas.

Research suggests that fibromyalgia may be linked to how the body processes pain, a condition known as central sensitization syndrome. It is more common in women, with approximately 6.4% of the U.S. population affected (7.7% in women and 4.9% in men). Studies in Europe and South America show similar rates, ranging from 3.3% to 8.3%. Fibromyalgia is more prevalent as people age, often affecting women between the ages of 20 and 55. Teenagers can also experience fibromyalgia at similar rates as adults, and in specialized pain clinics, over 40% of patients meet the criteria for the condition.

Fibromyalgia Treatment Market Companies

• Eli Lilly and Company
• Pfizer Inc.
• AbbVie Inc.
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• Sun Pharmaceuticals Industries Ltd.
• Novartis AG
• Astellas Pharma Inc.
• Aptinyx Inc.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/fibromyalgia-treatment-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5139

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare